论文部分内容阅读
目的探讨糖化血红蛋白(HbAlc)与急性脑梗死(ACI)患者病情严重程度及预后的影响。方法收集急性动脉粥样硬化性脑梗死患者269例,分为HbAlc正常组128例和HbAlc升高组141例,观察ACI预后。结果 HbAlc升高组神经功能缺损评分、脑梗死损伤程度明显高于HbAlc正常组。结论糖化血红蛋白是评估患者预后的有效指标之一,高HbAlc水平与ACI预后不良有关。
Objective To investigate the effects of glycosylated hemoglobin (HbAlc) and acute cerebral infarction (ACI) on the severity and prognosis of patients. Methods Totally 269 patients with acute atherosclerotic cerebral infarction were divided into HbAlc normal group (n = 128) and HbAlc elevated group (n = 141). The prognosis of ACI was observed. Results HbAlc increased neurological deficit score, cerebral infarction injury was significantly higher than the HbAlc normal group. Conclusions Glycated hemoglobin is one of the effective indicators to evaluate the prognosis of patients. The high HbAlc level is related to the poor prognosis of ACI.